Fora Capital, LLC Regenxbio Inc. Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$29.09 - $45.68 $102,949 - $161,661	-3,539 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $67,354 - $83,996	2,075 Added 141.73%	3,539 $137 Million
Q1 2021 May 17, 2021	SELL	$33.61 - $49.95 $56,464 - $83,916	-1,680 Reduced 53.44%	1,464 $50 Million
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $83,378 - $155,156	3,144 New	3,144 $142,000
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $88,429 - $222,924	-4,113 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $142,063 - $184,550	4,113 New	4,113 $168,000

193

43.5M

58.9K

58.4K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $404M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.